Can mesorectal lymph node excision be avoided in rectal cancer surgery?

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Rectal excision is the standard treatment for rectal cancer but carries significant morbidity.
• Radiochemotherapy can downstage rectal tumors, leading to a good response in many patients.
• The low rate of positive lymph nodes in responders suggests potential for less invasive treatments.

Purpose of the Study:

• To explore the concept of organ preservation in rectal cancer treatment.
• To evaluate nonoperative strategies and local excision for patients with a complete or subcomplete response after radiochemotherapy.
• To assess the suitability of local excision for organ preservation in downstaged rectal cancer.

Main Methods:

• Review of current treatment standards and emerging organ preservation strategies.
• Analysis of patient response to radiochemotherapy (complete or subcomplete response).
• Consideration of imaging modality limitations in assessing treatment response.

Main Results:

• A nonoperative strategy is feasible for patients with a complete response, requiring strict follow-up.
• Local excision is a viable option for patients with a complete or subcomplete response.
• Retrospective data suggest positive outcomes for local excision in downstaged T2/T3 low rectal cancer.

Conclusions:

• Organ preservation through nonoperative management or local excision is a promising approach for select rectal cancer patients.
• Local excision appears more appropriate than nonoperative management for most organ preservation candidates due to assessment limitations.
• Further confirmation from ongoing multicenter trials is necessary before widespread adoption of organ preservation strategies.